How many patents does
Beigene have?
patents
319
families
31
granted
72
applications
247
US
42
EP
31
CN
26
WO
24
JP
21
KR
13
RoW
162
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Beigene
Top ten assignees appearing on patents
2009 - 2018
| beigene | 260 |
| belgene | 2 |
| beigene, ltd. mourant ozannes corp… 🛈 | 2 |
| beigene switzerland | 1 |
2009
Beigene
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| fused tricyclic compounds as raf kinase inhibitors | 46 | 2011 |
| fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors | 45 | 2011 |
| fused heterocyclic compounds as protein kinase inhibitors | 38 | 2013 |
| anti-pd1 antibodies and their use as therapeutics and diagnostics | 30 | 2013 |
| fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors | 27 | 2011 |
| fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors | 26 | 2013 |
| substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones | 21 | 2013 |
| maleate salts of a b-raf kinase inhibitor, crystalline forms, methods of preparation, an… 🛈 | 15 | 2015 |
| fused tricyclic amide compounds as multiple kinase inhibitors | 12 | 2013 |
| process for preparing parp inhibitor, crystalline forms, and uses thereof | 11 | 2015 |